© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
The injectable hormone was approved to treat excess abdominal fat in those with antiretroviral-associated lipodystrophy.
A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.
Researchers have identified biomarkers that can identify NAFLD and rule out advanced fibrosis.
A review of the major findings presented at the Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco
Metabolic disorders are linked to liver scarring and fat accumulation in HIV-positive people.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
